AstraZeneca
The Director, Discovery Process and Analytical Development at Esobiotec (AstraZeneca group) is a senior R&D leader focused on advancing discovery-stage process and analytical capabilities for in vivo lentiviral vectors. The role supports translational readiness of discovery programs and integrates cross-functional scientific and operational perspectives. It sits within the organization’s research and development function driving cell and gene therapy innovation.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Business Development Manager
GenScript
Scientist, In Vivo CAR-T Pipeline
Legend Biotech
Scientific Director Genomic Medicines (f/m/d)
Cepheid
Director, Business Development - Eastern U.S.
Landmark Bio
Sr/Principal Scientist - Upstream Process Development
Genezen
Research Scientist [PDL Lab]
Brigham and Women's Hospital